Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00486 | 2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate | 107348-47-0 |
| Inquiry | ||
| BADC-00487 | perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate | 160580-70-1 |
| Inquiry | ||
| BADC-00488 | 2,5-dioxo-1-(3-(pyridin-2-yldisulfanyl)propanoyloxy)pyrrolidine-3-sulfonic acid | 121115-30-8 |
| SPDP-sulfo is a biomedical compound that has demonstrated its ability to combat various diseases. Because of its ability to expertly inhibit the tailor-made enzymes that control the progression of diseases such as cancer and inflammation, it emerges as a potential disease intervention tool. | Inquiry | |
| BADC-00489 | 4-((S)-2-((S)-2-amino-3-methylbutanamido)-5-ureidopentanamido)benzyl 2-(pyridin-2-yldisulfanyl)ethylcarbamate | 1610769-13-5 |
| PDP-C1-Ph-Val-Cit is a small molecule compound. It blocks specific enzymes involved in harmful processes of tumor expansion and metastasis, effectively inhibiting cancer progression. | Inquiry | |
| BADC-00490 | Boc-Phe-(Alloc)Lys-PAB-PNP | 1160844-44-9 |
| Boc-Phe-(Alloc)Lys-PAB-PNP is a complex biomedical compound being investigated as an innovative treatment for a variety of diseases, especially cancer. Known for its powerful properties, it effectively halts tumor progression through targeted neutralization of unique enzymes and pathways. | Inquiry | |
| BADC-00491 | Cbz-Phe-(Alloc)Lys-PAB-PNP | 159857-90-6 |
| Cbz-Phe-(Alloc)Lys-PAB-PNP is an important biomedical chemical product that has emerged as a potential therapeutic agent against various diseases. It has demonstrated outstanding capabilities as a candidate compound for targeted therapy against various malignancies, including breast and prostate cancer. This revolutionary compound, Cbz-Phe-(Alloc)Lys-PAB-PNP, utilizes its unique molecular structure to produce profound inhibitory effects on the proliferation of malignant cells. | Inquiry | |
| BADC-00492 | Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP | 253863-34-2 |
| Inquiry | ||
| BADC-00493 | Fmoc-Ala-Ala-Asn-PAB-PNP | 1834516-06-1 |
| Fmoc-Ala-Ala-Asn-PAB-PNP is an excellent and highly discriminating inhibitor widely used in biomedicine for multiple purposes. It is widely used in the field of drug development, especially in the targeted detection and attenuation of malignancies and cancers. | Inquiry | |
| BADC-00494 | Ala-Ala-Asn-PAB | 2149584-00-7 |
| Ala-Ala-Asn-PAB is a peptide derivative widely used in biomedical fields. The product is known for its superior chemical properties, which are highly advantageous in targeted drug delivery and enhanced therapeutic efficacy. Its broad applications include drug research for a variety of diseases, especially cancer. | Inquiry | |
| BADC-00495 | Fmoc-Phe-Lys(Trt)-PAB-PNP | 1116086-09-9 |
| Inquiry | ||
| BADC-00497 | sulfo-LC-SPDP | 150244-18-1 |
| Inquiry | ||
| BADC-00582 | Fmoc-PEG4-NHS ester | 1314378-14-7 |
| Fmoc-PEG4-NHS ester is a PEG derivative containing an Fmoc-protected amine and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The Fmoc group can be deprotected under basic conditions to obtain the free amine which can be used for further conjugations. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. | Inquiry | |
| BADC-00586 | Boc-NMe-Val-Val-Dil-Dap-OH | 1352202-13-1 |
| Boc-NMe-Val-Val-Dil-Dap-OH is a Lyn-derived linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00590 | DBCO-C6-NHS ester | 1384870-47-6 |
| Inquiry | ||
| BADC-00591 | DBCO-NHS ester 3 | 1393350-27-0 |
| Inquiry | ||
| BADC-00595 | 6-(Boc-amino)hexyl bromide | 142356-33-0 |
| Boc-NH-C6-Br is a cleavable linker used for antibody-drug conjugates (ADC). | Inquiry | |
| BADC-00621 | CL2A | 1846605-04-6 |
| CL2A is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker. | Inquiry | |
| BADC-00626 | 4-Formyl-N-(2-Methoxyethyl)benzamide | 199679-16-8 |
| 4-Formyl-N-(2-methoxyethyl)benzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00641 | SPDMB | 2101206-29-3 |
| Inquiry | ||
| BADC-00657 | SPDMV-sulfo | 2101206-86-2 |
| Inquiry |
